David F. Tough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David F. Tough has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Xiaohong Zhang
Department of Immunology, The Scripps Research Institute , La Jolla, CA 92037
4 shared publicationsJonathan Sprent
Department of Immunology, The Scripps Research Institute , La Jolla, CA 92037
3 shared publicationsSiquan Sun
3 shared publications- Filippo Belardelli
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy
2 shared publications Amanda L. Marzo
The Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire, UK
1 shared publicationAndrew T. Worth
Edward Jenner Institute for Vaccine Research, Compton, Newbury, Berkshire RG20 7NN, UK
1 shared publication
Latest Publications
- Open Access
- 28 March 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (4) , 925-934
A role for CD44 in T cell development and function during direct competition between CD44+ and CD44– cells
The role of CD44 in T cell biology remains incompletely understood. Although studies using anti‐CD44 antibodies have implicated this cell adhesion molecule in a variety of important T cell processes, few T cell defects have been reported in CD44‐deficient mice. We have assessed the requirement for CD44 in T cell development and mature T cell function by analyzing mice in which CD44–/– and WT cells were produced simultaneously. In mixed (CD44–/– + CD44+/+) bone marrow chimeras, production of CD44–/– T cells was shown to be reduced compared to WT cells due to inefficient intrathymic development. In addition, mature CD44–/– CD8+ T cells generated a substantially lower response than WT T cells after infection of mice with lymphocytic choriomeningitis virus, with the reduction in response apparent in both lymphoid and non‐lymphoid tissues. Overall, these results demonstrate a poor capacity of CD44–/– T lineage cells to compete with WT cells at multiple levels, implicating CD44 in normal T cell function.
- 28 March 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (4) , 925-934
Open AccessA role for CD44 in T cell development and function during direct competition between CD44+ and CD44– cells
The role of CD44 in T cell biology remains incompletely understood. Although studies using anti‐CD44 antibodies have implicated this cell adhesion molecule in a variety of important T cell processes, few T cell defects have been reported in CD44‐deficient mice. We have assessed the requirement for CD44 in T cell development and mature T cell function by analyzing mice in which CD44–/– and WT cells were produced simultaneously. In mixed (CD44–/– + CD44+/+) bone marrow chimeras, production of CD44–/– T cells was shown to be reduced compared to WT cells due to inefficient intrathymic development. In addition, mature CD44–/– CD8+ T cells generated a substantially lower response than WT T cells after infection of mice with lymphocytic choriomeningitis virus, with the reduction in response apparent in both lymphoid and non‐lymphoid tissues. Overall, these results demonstrate a poor capacity of CD44–/– T lineage cells to compete with WT cells at multiple levels, implicating CD44 in normal T cell function.
- 30 June 2006
- Published by Wiley in European Journal of Immunology
- Vol. 36 (7) , 1827-1836
Modification of TLR‐induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists
Upon detection of direct and indirect signs of infection, dendritic cells (DC) undergo functional changes that modify their ability to elicit immune responses. Type I interferon (IFN‐α/β), which includes a large family of closely related infection‐inducible cytokines, represents one indirect signal that can act as a DC stimulus. We have investigated the ability of IFN‐α/β subtypes to affect DC function and to influence DC responses to Toll‐like receptor (TLR) agonists (i.e., direct infection‐associated signals). Subtle differences were observed among 15 subtypes of IFN‐α/β in the ability to stimulate expression of maturation markers and chemokines by human monocyte‐derived DC, with IFN‐ω being the most unique in its effects. Pre‐treatment with IFN‐α/β did not alter the ability of DC to mature in response to subsequent contact with TLR agonists, but did modulate their secretion of chemokines. Conversely, IFN‐α/β was shown to act synergistically with TLR4 but not TLR3 agonists for the induction of maturation and chemokine production when DC were exposed to IFN‐α/β and TLR ligands simultaneously. Taken together, these results indicate a complex role for IFN‐α/β in regulating DC function during the course an infection, which varies according to IFN‐α/β subtype and the timing of exposure to other stimuli.
- 30 June 2006
- Published by Wiley in European Journal of Immunology
- Vol. 36 (7) , 1827-1836
Modification of TLR‐induced activation of human dendritic cells by type I IFN: synergistic interaction with TLR4 but not TLR3 agonists
Upon detection of direct and indirect signs of infection, dendritic cells (DC) undergo functional changes that modify their ability to elicit immune responses. Type I interferon (IFN‐α/β), which includes a large family of closely related infection‐inducible cytokines, represents one indirect signal that can act as a DC stimulus. We have investigated the ability of IFN‐α/β subtypes to affect DC function and to influence DC responses to Toll‐like receptor (TLR) agonists (i.e., direct infection‐associated signals). Subtle differences were observed among 15 subtypes of IFN‐α/β in the ability to stimulate expression of maturation markers and chemokines by human monocyte‐derived DC, with IFN‐ω being the most unique in its effects. Pre‐treatment with IFN‐α/β did not alter the ability of DC to mature in response to subsequent contact with TLR agonists, but did modulate their secretion of chemokines. Conversely, IFN‐α/β was shown to act synergistically with TLR4 but not TLR3 agonists for the induction of maturation and chemokine production when DC were exposed to IFN‐α/β and TLR ligands simultaneously. Taken together, these results indicate a complex role for IFN‐α/β in regulating DC function during the course an infection, which varies according to IFN‐α/β subtype and the timing of exposure to other stimuli.
- 1 February 2006
- Published by Springer Nature in Nature Immunology
- Vol. 7 (2) , 127-128
'3d' effects on global immunity
- 1 February 2006
- Published by Springer Nature in Nature Immunology
- Vol. 7 (2) , 127-128
'3d' effects on global immunity
- Open Access
- 12 July 2004
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 200 (2) , 255-260
Rapid Turnover of Effector–Memory CD4+ T Cells in Healthy Humans
Memory T cells can be divided into central–memory (TCM) and effector–memory (TEM) cells, which differ in their functional properties. Although both subpopulations can persist long term, it is not known whether they are maintained by similar mechanisms. We used in vivo labeling with deuterated glucose to measure the turnover of CD4+ T cells in healthy humans. The CD45R0+CCR7− TEM subpopulation was shown to have a rapid proliferation rate of 4.7% per day compared with 1.5% per day for CD45R0+CCR7+ TCM cells; these values are equivalent to average intermitotic (doubling) times of 15 and 48 d, respectively. In contrast, the CD45RA+CCR7+ naive CD4+ T cell population was found to be much longer lived, being labeled at a rate of only 0.2% per day (corresponding to an intermitotic time of approximately 1 yr). These data indicate that human CD4+ TEM cells constitute a short-lived cell population that requires continuous replenishment in vivo.
- 12 July 2004
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 200 (2) , 255-260
Open AccessRapid Turnover of Effector–Memory CD4+ T Cells in Healthy Humans
Memory T cells can be divided into central–memory (TCM) and effector–memory (TEM) cells, which differ in their functional properties. Although both subpopulations can persist long term, it is not known whether they are maintained by similar mechanisms. We used in vivo labeling with deuterated glucose to measure the turnover of CD4+ T cells in healthy humans. The CD45R0+CCR7− TEM subpopulation was shown to have a rapid proliferation rate of 4.7% per day compared with 1.5% per day for CD45R0+CCR7+ TCM cells; these values are equivalent to average intermitotic (doubling) times of 15 and 48 d, respectively. In contrast, the CD45RA+CCR7+ naive CD4+ T cell population was found to be much longer lived, being labeled at a rate of only 0.2% per day (corresponding to an intermitotic time of approximately 1 yr). These data indicate that human CD4+ TEM cells constitute a short-lived cell population that requires continuous replenishment in vivo.
- 1 February 2004
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (2) , 257-264
Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation
Type I interferon (IFN-α/β) is expressed rapidly after infection and plays a key role in innate defense against pathogens. Recent studies have shown that a connection exists between IFN-α/β and antigen-presenting dendritic cells (DCs) at two levels. Firstly, a specific DC precursor, the plasmacytoid pre-DC (p-preDC), was identified as a cell type able to secrete very high amounts of IFN-α/β following stimulation with infectious agents. Secondly, IFN-α/β has been shown to act as a differentiation/maturation factor for DCs. These findings will be discussed in association with evidence indicating that IFN-α/β can enhance and modulate immune responses in vivo. Taken together, the available data suggest that IFN-α/β serves as a link between the innate response to infection and the adaptive immune response.
- 1 February 2004
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 45 (2) , 257-264
Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation
Type I interferon (IFN-α/β) is expressed rapidly after infection and plays a key role in innate defense against pathogens. Recent studies have shown that a connection exists between IFN-α/β and antigen-presenting dendritic cells (DCs) at two levels. Firstly, a specific DC precursor, the plasmacytoid pre-DC (p-preDC), was identified as a cell type able to secrete very high amounts of IFN-α/β following stimulation with infectious agents. Secondly, IFN-α/β has been shown to act as a differentiation/maturation factor for DCs. These findings will be discussed in association with evidence indicating that IFN-α/β can enhance and modulate immune responses in vivo. Taken together, the available data suggest that IFN-α/β serves as a link between the innate response to infection and the adaptive immune response.
- 1 August 2003
- Published by Elsevier in Trends in Immunology
- Vol. 24 (8) , 404-407
Deciphering the relationship between central and effector memory CD8+ T cells
- 1 August 2003
- Published by Elsevier in Trends in Immunology
- Vol. 24 (8) , 404-407
Deciphering the relationship between central and effector memory CD8+ T cells
- 29 May 2002
- Published by Wiley in Immunology
- Vol. 106 (2) , 127-138
Qualitative differences between naïve and memory T cells
- 29 May 2002
- Published by Wiley in Immunology
- Vol. 106 (2) , 127-138
Qualitative differences between naïve and memory T cells
- 1 December 2001
- Published by Springer Nature in Nature Immunology
- Vol. 2 (12) , 1098-100
Interferon with dendritic cells?
- 1 December 2001
- Published by Springer Nature in Nature Immunology
- Vol. 2 (12) , 1098-100
Interferon with dendritic cells?
- Open Access
- 1 August 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (3) , 1179-1187
IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation
Cytokines that are induced by infection may contribute to the initiation of immune responses through their ability to stimulate dendritic cells (DCs). In this paper, we have addressed the role of IL-15 in DC activation, investigating its expression by DCs in response to three different signals of infection and examining its ability to stimulate DCs. We report that the expression of both IL-15 and the IL-15 receptor α-chain are increased in splenic DCs from mice inoculated with dsRNA (poly(I:C)), LPS, or IFN-αβ, and in purified murine splenic DCs treated with IFN-αβ in vitro. Furthermore, IL-15 itself was able to activate DCs, as in vivo or in vitro exposure of splenic DCs to IL-15 resulted in an up-regulation of costimulatory molecules, markedly increased production of IFN-γ by DC and an enhanced ability of DCs to stimulate Ag-specific CD8+ T cell proliferation. The magnitude of all of the IL-15-induced changes in DCs was reduced in mice deficient for the IFN-αβ receptor, suggesting a role for IFN-αβ in the stimulation of DCs by IL-15. These results identify IL-15 as a stimulatory cytokine for DCs with the potential for autocrine activity and link its effects to expression of IFN-αβ.
- 1 August 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 167 (3) , 1179-1187
Open AccessIL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation
Cytokines that are induced by infection may contribute to the initiation of immune responses through their ability to stimulate dendritic cells (DCs). In this paper, we have addressed the role of IL-15 in DC activation, investigating its expression by DCs in response to three different signals of infection and examining its ability to stimulate DCs. We report that the expression of both IL-15 and the IL-15 receptor α-chain are increased in splenic DCs from mice inoculated with dsRNA (poly(I:C)), LPS, or IFN-αβ, and in purified murine splenic DCs treated with IFN-αβ in vitro. Furthermore, IL-15 itself was able to activate DCs, as in vivo or in vitro exposure of splenic DCs to IL-15 resulted in an up-regulation of costimulatory molecules, markedly increased production of IFN-γ by DC and an enhanced ability of DCs to stimulate Ag-specific CD8+ T cell proliferation. The magnitude of all of the IL-15-induced changes in DCs was reduced in mice deficient for the IFN-αβ receptor, suggesting a role for IFN-αβ in the stimulation of DCs by IL-15. These results identify IL-15 as a stimulatory cytokine for DCs with the potential for autocrine activity and link its effects to expression of IFN-αβ.
- 15 May 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (10) , 6007-6011
An IFN-γ-Dependent Pathway Controls Stimulation of Memory Phenotype CD8+ T Cell Turnover In Vivo by IL-12, IL-18, and IFN-γ
Unlike naive T cells, memory phenotype (CD44high) T cells exhibit a high background rate of turnover in vivo. Previous studies showed that the turnover of memory phenotype CD8+ (but not CD4+) cells in vivo can be considerably enhanced by products of infectious agents such as LPS. Such stimulation is TCR independent and hinges on the release of type I IFNs (IFN-I) which leads to the production of an effector cytokine, probably IL-15. In this study, we describe a second pathway of CD44high CD8+ stimulation in vivo. This pathway is IFN-γ rather than IFN-I dependent and is mediated by at least three cytokines, IL-12, IL-18, and IFN-γ. As for IFN-I, these three cytokines are nonstimulatory for purified T cells and under in vivo conditions probably act via production of IL-15.
- 15 May 2001
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (10) , 6007-6011
An IFN-γ-Dependent Pathway Controls Stimulation of Memory Phenotype CD8+ T Cell Turnover In Vivo by IL-12, IL-18, and IFN-γ
Unlike naive T cells, memory phenotype (CD44high) T cells exhibit a high background rate of turnover in vivo. Previous studies showed that the turnover of memory phenotype CD8+ (but not CD4+) cells in vivo can be considerably enhanced by products of infectious agents such as LPS. Such stimulation is TCR independent and hinges on the release of type I IFNs (IFN-I) which leads to the production of an effector cytokine, probably IL-15. In this study, we describe a second pathway of CD44high CD8+ stimulation in vivo. This pathway is IFN-γ rather than IFN-I dependent and is mediated by at least three cytokines, IL-12, IL-18, and IFN-γ. As for IFN-I, these three cytokines are nonstimulatory for purified T cells and under in vivo conditions probably act via production of IL-15.